11 days agoDHA Shifts Acquisition Toward Warfighter Readiness and Measurable Results
Defense Health Agency acquisition leader Matthew Clark is using a 30-60-90-day DELIVER Care transition plan to align research, acquisition, and contracting with warfighter readiness and faster delivery. DHA is signaling closer portfolio oversight, with the Data Exchange Platform and a research-support multiple-award IDIQ identified as areas of interest, but no solicitation or award details have been announced.
107 days agoDHA Awards $300M Contract for Deployment Support Services
The Defense Health Agency has awarded a $300 million contract to 12 firms for healthcare IT deployment support. This contract's lengthy duration highlights the ongoing demand for IT modernization within the military health system. Contractors should align their offerings with DHA's digital initiatives, particularly the MHS GENESIS rollout.
170 days agoDARPA's RAPIID Program Aims for Shelf-Stable Blood Substitute by FY2029
DARPA's RAPIID program intends to create synthetic blood substitutes for battlefield use, targeting FDA approval by FY2029. The program seeks proposals addressing blood component development and delivery technologies, presenting a robust opportunity landscape for companies in medical innovation and regulatory compliance.